Molecular and physiological aspects of tissue renin-angiotensin system: emphasis on cardiovascular control
- PMID: 3066879
Molecular and physiological aspects of tissue renin-angiotensin system: emphasis on cardiovascular control
Abstract
Angiotensin II (Ang II), an important peptide in cardiovascular physiology, is the product of enzymatic processing of angiotensinogen which involves two proteolytic steps carried out by renin and angiotensin converting enzyme (ACE) sequentially. This system, which plays an important role in cardiorenal homeostasis, is conventionally considered an endocrine system. Increasing evidence supports the existence of this biochemical cascade in many tissues, in addition to its presence in the circulation. The molecular demonstration of tissue renin and angiotensinogen gene expressions suggest that the presence of this system is due, at least in part, to local synthesis. These observations have led to the hypothesis that locally generated angiotensin may be important in the regulation of individual tissue function, in addition to its circulating counterpart. This emerging concept may be important in providing an additional understanding of the role of renin angiotensin in cardiovascular physiology and in the response to pharmacological inhibitors of this system.
Similar articles
-
[The current concept of the renin-angiotensin system].Rev Invest Clin. 1993 Mar-Apr;45(2):165-77. Rev Invest Clin. 1993. PMID: 8337545 Review. Spanish.
-
Circulating versus local renin-angiotensin system in cardiovascular homeostasis.Circulation. 1988 Jun;77(6 Pt 2):I4-13. Circulation. 1988. PMID: 3286045 Review.
-
Localization of components of the renin-angiotensin system and site of action of inhibitors.Arzneimittelforschung. 1993 Feb;43(2A):214-21. Arzneimittelforschung. 1993. PMID: 8498967 Review.
-
Brain angiotensin II and synaptic transmission.Neuroscientist. 2004 Oct;10(5):422-31. doi: 10.1177/1073858404264678. Neuroscientist. 2004. PMID: 15359009 Review.
-
Tissue renin-angiotensin systems. Their role in cardiovascular disease.Circulation. 1993 May;87(5 Suppl):IV7-13. Circulation. 1993. PMID: 8485836 Review.
Cited by
-
ACE inhibitors for heart failure: a question of dose.Br Heart J. 1994 Sep;72(3 Suppl):S106-10. doi: 10.1136/hrt.72.3_suppl.s106. Br Heart J. 1994. PMID: 7946796 Free PMC article. Review. No abstract available.
-
Multiple dose pharmacokinetics and concentration effect relationship of the orally active renin inhibitor remikiren (Ro 42-5892) in hypertensive patients.Br J Clin Pharmacol. 1993 Dec;36(6):547-54. doi: 10.1111/j.1365-2125.1993.tb00413.x. Br J Clin Pharmacol. 1993. PMID: 12959271 Free PMC article. Clinical Trial.
-
Role of ACE/AT2R complex in the control of mesenteric resistance artery contraction induced by ACE/AT1R complex activation in response to Ang I.Mol Cell Biochem. 2008 Apr;311(1-2):1-7. doi: 10.1007/s11010-007-9686-0. Epub 2007 Dec 13. Mol Cell Biochem. 2008. PMID: 18084722 Free PMC article.
-
Tissue angiotensin-converting enzyme in patients with various clinical forms of psoriasis.Bosn J Basic Med Sci. 2007 May;7(2):103-6. doi: 10.17305/bjbms.2007.3061. Bosn J Basic Med Sci. 2007. PMID: 17489742 Free PMC article.
-
Angiotensin II-forming heart chymase is a mast-cell-specific enzyme.Biochem J. 1991 Jun 1;276 ( Pt 2)(Pt 2):567-8. doi: 10.1042/bj2760567. Biochem J. 1991. PMID: 2049082 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous